HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Postpartum infection of vulva — Clinical Guidelines

Overview

Postpartum vulvar infections are complications that can occur following childbirth, particularly after cesarean delivery, characterized by signs of inflammation and potential systemic symptoms if severe 1 3.

Diagnosis

Clinical signs include redness, swelling, pain, and purulent discharge 1 3.

Laboratory tests: Cultures from wound sites or vaginal swabs to identify pathogens 1 7.

Imaging: Not typically required unless there are signs of deeper tissue involvement 10.

Management

First-line treatment: Prophylactic antibiotics such as cephalexin and metronidazole for cesarean deliveries in high-risk groups (e.g., obesity) 1.

Adjunctive therapy: Azithromycin may be considered for unscheduled cesarean deliveries, with timing of administration influencing outcomes 4.

Duration: Typically 48 hours post-delivery, but may extend based on clinical response 1.

Monitoring: Regular follow-up to assess resolution and detect complications 9.

Special Populations

Obesity: Higher risk of postpartum infection; prophylactic antibiotics recommended 1.

VBAC (Vaginal Birth After Cesarean): Prophylactic antibiotics reduce maternal infection rates 5.

Infant Impact: Antibiotic prophylaxis during cesarean delivery has limited impact on infant gut microbiome 2.

Key Recommendations

Prophylactic antibiotics for cesarean deliveries in obese women to reduce infection complications 1 (Evidence: Strong).

Regular post-discharge surveillance for up to 30 days to detect nosocomial surgical site infections after cesarean section 9 (Evidence: Moderate).

Implement infection control programs including aseptic techniques and refresher courses for surgical teams to mitigate modifiable risk factors 7 (Evidence: Moderate).

Consider timing of adjunctive azithromycin in unscheduled cesarean deliveries to optimize maternal outcomes 4 (Evidence: Moderate).

Evaluate and treat asymptomatic bacteriuria promptly, with spontaneous resolution common by the third postpartum day 13 (Evidence: Moderate).

References

1 Saad AF, Goldman B, Spencer N, Kuhlmann M, McDonnold M, Saade GR. Prophylactic Oral Cephalexin and Metronidazole Compared With Placebo After Cesarean Delivery to Reduce Infection Complications in Women With Obesity: A Randomized Controlled Trial. Obstetrics and gynecology 2025. link 2 Sinha T, Prins JR, Fernández-Pato A, Kruk M, Dierikx T, de Meij T et al.. Maternal antibiotic prophylaxis during cesarean section has a limited impact on the infant gut microbiome. Cell host & microbe 2024. link 3 Lamfel R, Snyman L, Seopela L, Jahn G, Becker P. Early online. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2024. link 4 Sanusi A, Ye Y, Boggess K, Saade G, Longo S, Clark E et al.. Timing of Adjunctive Azithromycin for Unscheduled Cesarean Delivery and Postdelivery Infection. Obstetrics and gynecology 2022. link 5 Sofer D. UK Study Finds Benefit to Prophylactic Antibiotics After Operative Vaginal Births. The American journal of nursing 2019. link 6 Scott JR. Intrapartum management of trial of labour after caesarean delivery: evidence and experience. BJOG : an international journal of obstetrics and gynaecology 2014. link 7 Salim R, Braverman M, Teitler N, Berkovic I, Suliman A, Shalev E. Risk factors for infection following cesarean delivery: an interventional study. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2012. link 8 Van Beneden CA, Hicks LA, Riley LE, Schulkin J. Provider knowledge, attitudes, and practices regarding obstetric and postsurgical gynecologic infections due to group A Streptococcus and other infectious agents. Infectious diseases in obstetrics and gynecology 2007. link 9 Couto RC, Pedrosa TM, Nogueira JM, Gomes DL, Neto MF, Rezende NA. Post-discharge surveillance and infection rates in obstetric patients. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 1998. link00047-2) 10 Calhoun BC, Brost B. Emergency management of sudden puerperal fever. Obstetrics and gynecology clinics of North America 1995. link 11 Viglionese A, Nottebart VF, Bodman HA, Platt R. Recurrent group A streptococcal carriage in a health care worker associated with widely separated nosocomial outbreaks. The American journal of medicine 1991. link90391-a) 12 Filker RS, Monif GR. Postpartum septicemia due to group G streptococci. Obstetrics and gynecology 1979. link 13 Marraro RV, Harris RE. Incidence and spontaneous resolution of postpartum bacteriuria. American journal of obstetrics and gynecology 1977. link90710-4)

Postpartum infection of vulva